The Possible Role of Probiotics in Combating COVID-19
DOI:
https://doi.org/10.24871/2132020226-230Abstract
Since first reported in Wuhan in the end of 2019, COVID-19 infection has spread globally. However, our battle against COVID-19 is still limited with treatment modalities, yet giving a big challenge for researchers to explore promising treatment candidate. Probiotics, based on previous studies of its role in immune system and respiratory tract infection, seem to be potential candidate. Probiotics work in a distinct way through connectivity between gut and the lung, since both have expression of angiotensin converting enzyme2 (ACE2) of which highly bound by COVID-19. At present, no guidelines formally include probiotics as part of COVID-19 treatment. Hence, this study aimed to review the link of probiotics and immune system and its potential role as part of COVID-19 treatment.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).










